Navigation Links
BioScrip Reports First Quarter 2013 Financial Results
Date:5/8/2013

the end of the first quarter was zero and outstanding borrowings under its revolving credit facility was approximately $28.0 million as it utilized a combination of its available cash and borrowings under its revolving credit facility to fund the acquisition of HomeChoice.  Subsequent to the end of the first quarter, the Company raised net proceeds of $118.6 million from a public offering of its common stock and used part of such net proceeds to pay down outstanding amounts under its revolving credit facility.

Outlook
The Company reaffirms its initial 2013 revenue target of $830.0 million to $865.0 million and 2013 Adjusted EBITDA target of $67.0 million to $73.0 million.

Conference Call
BioScrip will host a conference call to discuss its first quarter 2013 financial results on May 9, 2013 at 8:30 a.m. Eastern Time.

Interested parties may participate in the conference call by dialing 800-705-5308 (US), or 303-223-4377 (International), 5-10 minutes prior to the start of the call. A replay of the conference call will be available for two weeks after the call's completion by dialing 800-633-8284 (US) or 402-977-9140 (International) and entering conference call ID number 21656383. An audio webcast and archive will also be available for 30 days under the "Investor Relations" section of the BioScrip website at www.bioscrip.com.

About BioScrip, Inc.
BioScrip, Inc. provides comprehensive infusion and home care solutions. By partnering with patients, physicians, healthcare payors, government agencies and pharmaceutical manufacturers we are able to provide access to infusible medications and management solutions. Our goal is to optimize outcomes for chronic and other complex healthcare conditions and enhance the quality of patient life. BioScrip brings clinical competence in providing high-touch, comprehensive infusion and nursing services to patients in the most convenient ways possible.
'/>"/>

SOURCE BioScrip, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. BioScrip To Present At "NINE" Noble Financial Capital Markets Ninth Annual Equity Conference
2. China Biologic Reports Financial Results for the First Quarter of 2013
3. Nephros Reports First Quarter 2013 Financial Results
4. PharmAthene Reports First Quarter 2013 Financial And Operational Results
5. Avanir Pharmaceuticals Reports Fiscal 2013 Second Quarter Financial and Business Results
6. Sangamo BioSciences Reports First Quarter 2013 Financial Results
7. AcelRx Pharmaceuticals Reports First Quarter 2013 Financial Results
8. Halozyme Reports First Quarter 2013 Financial Results
9. Depomed Reports First Quarter 2013 Financial Results
10. InspireMD Reports Financial Results For Period Ended March 31, 2013
11. Isis Reports Financial Results and Highlights for First Quarter 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... (NYSE: CVS ) officially announced today that it will rebuild ... fire damage during protests last week.  "As we watched ... past week or so, our hearts turned from pain to the ... Larry Merlo . "Our purpose as a company is helping ... way that we can fulfill that purpose than to reopen our ...
(Date:5/6/2015)... 6, 2015 Fibich, Leebron, Copeland, Briggs & ... settlement has been reached to resolve lawsuits involving individuals ... Actos. Actos - manufactured by Takeda Pharmaceuticals - has ... cancer. Several of the firm,s attorneys were instrumental in ... Tommy Fibich - Founding Partner of Fibich, ...
(Date:5/6/2015)... Research and Markets ( http://www.researchandmarkets.com/research/jskhnb/energy_based ) has ... - Global Strategic Business Report" report to their offering. ... US, Canada , Japan ... , and Rest of World. Annual estimates and forecasts are ... historic analysis is provided for these markets. The ...
Breaking Medicine Technology:CVS Health Announces it Will Rebuild Baltimore CVS/pharmacy Locations 2Takeda Agrees to $2.4 Billion Settlement for Actos Bladder Cancer Lawsuits 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 3
... 15, 2011 Nephros, Inc. (OTC Bulletin Board: ... marketing filtration products for therapeutic applications, infection control, and ... Inc. effected a one-for-twenty reverse stock split at 5:00 ... by the Financial Industry Regulatory Authority (FINRA) that FINRA ...
... and BALTIMORE, March 15, 2011 ... innovate, implement and commercialize next generation of medical image ... leading clinicians and advanced engineering technologists. ... international communications and information technology company, and Johns Hopkins ...
Cached Medicine Technology:Nephros Announces Split Adjusted Trade Date 2Nephros Announces Split Adjusted Trade Date 3Harris Corporation and Johns Hopkins Medicine Announce Joint Venture to Develop Innovative Medical Image Management Solutions 2
(Date:5/6/2015)... Falls Church, VA (PRWEB) May 07, 2015 ... the Impact of NSF/IPEC/ANSI 363-2014, **FDAnews Webinar**, May ... EDT, http://www.fdanews.com/NewGMPStandards , Most drugs contain ... flow aids, binding agents or other purposes that ... The globalization of the pharma industry, combined with ...
(Date:5/6/2015)... With recent headlines about the kidnapping of Bossini clothing ... from Southern China, it is becoming apparent to people all ... them. This is especially true for High Net Worth Individuals ... through the property they own, the schools their children attend ... individuals, families and companies that are at higher risk than ...
(Date:5/6/2015)... Jersey (PRWEB) May 06, 2015 With ... asthma and subject to its potentially dangerous health effects, ... state-wide program – BEAM (Breathe Easier with Asthma Management) ... The program is being funded through a $500,000 foundation ... Jersey (BGCNJ), which is implementing BEAM throughout the state. ...
(Date:5/6/2015)... As the exclusive hospital of the Tampa Bay Buccaneers, Florida ... Raymond James Stadium for all the “Bucs Babies” celebrating their ... into the “Bucs Babies” program last year. , “It ... particularly those born at the Florida Hospitals here in our ... really enjoyed my time participating in the festivities, interacting with ...
(Date:5/6/2015)... Beach, VA (PRWEB) May 06, 2015 ... and services, today announced it won the Software ... CODiE Award in the "Best Postsecondary Learning Management ... in 2011 and has been finalists for this award ... and innovation that stands out in the industry. ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — New Standards for Excipient GMPs: Analyzing the Impact of NSF/IPEC/ANSI 363-2014 Webinar, May 27, 2015 2Health News:FDAnews Announces — New Standards for Excipient GMPs: Analyzing the Impact of NSF/IPEC/ANSI 363-2014 Webinar, May 27, 2015 3Health News:Pacific Prime China Now Offering Kidnapping & Ransom Insurance 2Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 2Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 3Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 4Health News:Florida Hospital and the Tampa Bay Buccaneers Celebrate “Bucs Babies” Who are Turning One this Month with a Party on the Pirate Ship 2Health News:Florida Hospital and the Tampa Bay Buccaneers Celebrate “Bucs Babies” Who are Turning One this Month with a Party on the Pirate Ship 3Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 2Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 3
... Neurobiological,Technologies, Inc. ("NTI") (Nasdaq: NTII ) today ... by The NASDAQ Stock Market that it has,regained ... Previously, the NASDAQ Listing Qualifications Department had,notified NTI ... $35 million market,value of listed securities continued listing ...
... for Baby Boomers In ... Search of Better Sex, ... during the,holidays that recipients will love. But one product is, in ... ), To view the Multimedia News Release, go to: ...
... November 20 Stora Enso, a leading producer,of ... the first,intelligent pharmaceutical packaging solution to use Cypak,s ... electronic module built,around a single RFID microchip and ... sensors are printed onto the packaging,to detect when ...
... WHO Cuts Global AIDS Estimate by Six Million; AHF Questions Numbers, Seeks ... ... As the World Health,Organization (WHO) prepares to announce a dramatic decrease in ... to 33,million in a report to be released Wednesday, AIDS Healthcare Foundation,(AHF) ...
... MYL ),announced that it completed the sale of 2.14 ... per share and 53.5 million,shares of common stock at ... filed with the Securities and Exchange Commission. The,amounts sold ... underwriters, exercise of the overallotment option. The offerings ...
... Viant, Inc., a leader in,healthcare payment and cost ... as Executive Vice President of Network,Development. Mr. Vangeison ... on delivering quality and value to many of ... Vangeison will have responsibility for all network strategy,including ...
Cached Medicine News:Health News:Give the Gift of Love With Women's Intimacy Product that Increases Pleasure for Both Partners 2Health News:Give the Gift of Love With Women's Intimacy Product that Increases Pleasure for Both Partners 3Health News:Cypak Compliancy Connection Powers Stora Enso Pharma DDSi 2Health News:WHO's New Global AIDS Numbers: 'Let's Stop Guessing,' Says AHF 2Health News:Mylan Completes $2.89 Billion of Equity Financings, Including Exercise of Overallotment Option of Mandatory Convertible Preferred Stock 2Health News:Mylan Completes $2.89 Billion of Equity Financings, Including Exercise of Overallotment Option of Mandatory Convertible Preferred Stock 3Health News:Viant Appoints Keith Vangeison as Executive Vice President of Network Development 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: